Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Other Accumulated Expenses (2016 - 2017)

Dare Bioscience (DARE) has disclosed Other Accumulated Expenses for 5 consecutive years, with $120000.0 as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Other Accumulated Expenses fell 83.07% year-over-year to $120000.0, compared with a TTM value of $120000.0 through Jun 2017, down 83.07%, and an annual FY2016 reading of $575000.0, down 34.88% over the prior year.
  • Other Accumulated Expenses was $120000.0 for Q2 2017 at Dare Bioscience, down from $300000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $883000.0 in Q4 2015 and bottomed at $17000.0 in Q3 2015.
  • Average Other Accumulated Expenses over 5 years is $351266.7, with a median of $332000.0 recorded in 2014.
  • The sharpest move saw Other Accumulated Expenses tumbled 94.99% in 2015, then soared 3264.71% in 2016.
  • Year by year, Other Accumulated Expenses stood at $379000.0 in 2013, then crashed by 91.03% to $34000.0 in 2014, then soared by 2497.06% to $883000.0 in 2015, then plummeted by 34.88% to $575000.0 in 2016, then tumbled by 79.13% to $120000.0 in 2017.
  • Business Quant data shows Other Accumulated Expenses for DARE at $120000.0 in Q2 2017, $300000.0 in Q1 2017, and $575000.0 in Q4 2016.